A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/48 (2006.01) A61K 35/74 (2006.01) A61K 38/16 (2006.01) A61K 47/18 (2006.01) A61K 47/36 (2006.01) A61K 47/42 (2006.01) C12P 21/02 (2006.01)
Patent
CA 2494241
A botulinum toxin pharmaceutical composition free of blood derived albumin, comprising a botulinum toxin, sodium chloride or water and a polysaccharide such as a hydroxyethyl starch and/or an amino acid, the pharmaceutical composition being suitable for therapeutic administration to a human patient. Alternatively, the polysaccharide and amino acid can be replaced by recombinant albumin.
L'invention porte sur une composition pharmaceutique à base de toxine botulique exempte d'albumine d'origine sanguine. Cette composition contient la toxine botulique, du chlorure de sodium ou de l'eau, et un polysaccharide comme un amidon hydroxyéthylé et/ou un acide aminé. La composition pharmaceutique est destinée à être administrée à un patient à des fins de traitement. Aussi, le polysaccharide et l'acide aminé peuvent être remplacés par de l'albumine recombinante.
Allergan Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Botulinum toxin pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Botulinum toxin pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Botulinum toxin pharmaceutical compositions will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2030007